News

The data safety monitoring board (DSMB) meeting reviewed 28-week data for approximately 50% of the patients in the study. The DSMB noted in their report very few dropouts

Upon completion of the research studies, the agreement provides Cerner an option for exclusive licensing of University of New Mexico Health Sciences Center’s (UNMHSC) technology for clinical and

Oramed plans to start Phase IIA clinical trials in Israel in the second quarter of 2008. The Phase IIA study is designed to evaluate the safety and efficacy

Datascope will retain approximately $38 million of receivables generated by the patient monitoring business. The transaction has been approved by the Datascope and Mindray boards of directors and

The companies will focus on phage-based products that could help the animal health and food production industries in their struggle to control outbreaks of human pathogenic bacteria such

Schering-Plough is seeking FDA approval to sell the product in the US over-the-counter (OTC) heartburn market. The NDA was submitted under the terms of a license agreement signed

This multi-center, double-blind, randomized and placebo-controlled clinical trial compares the safety and efficacy of prulifloxacin versus placebo in adult travelers suffering acute bacterial gastroenteritis. Clinical trial sites included

This study examines the safety of its lead candidate, new HspE7 (HspE7 + Poly-ICLC, a toll-like receptor-3, or TLR3 agonist), in patients with cervical intraepithelial neoplasia (CIN), a

This trial is being conducted in Europe in healthy volunteers and is designed to help define dosing regimens to assess in patients with inflammatory diseases and cancer. Daryl